Neurocrine Biosciences Inc (NASDAQ:NBIX)
| 117.06 Delayed Data As of Jan 22 |  +1.91 / +1.66%Today’s Change | 72.14 Today|||52-Week Range 136.26 | +22.13% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $10.9B |
Company Description
Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.
Contact Information
Neurocrine Biosciences, Inc. 12780 El Camino Real San Diego California 92130 |
Employees
Shareholders
| Individual stakeholders | 8.53% |
| Mutual fund holders | 66.02% |
| Other institutional | 31.95% |
Top Executives
| Kevin Charles Gorman | Chief Executive Officer & Director |
| Matthew C. Abernethy | Chief Financial Officer |
| Dimitri E. Grigoriadis | Chief Research Officer |
| Bill Wilson | Vice President-Information Technology & Operations |
| Eiry W. Roberts | Chief Medical Officer |
